《新股消息》勛龍(01930.HK)目前貿易戰對公司實際影響很小
勛龍(01930.HK)目前生產工廠位於內地昆山及青島。主席兼行政總裁林萬益在記者會上表示,計劃在現有的昆山廠房旁邊興建一個新廠房,料會在2020年上半年完全落成,相信產能有望增加30%。
被問及中美貿易戰會否對公司的汽車模具業務帶來影響時,他回應指看到貿易磨擦對其下游客戶帶來影響,但認為更大的是在心理影響上,目前對公司的實際影響很小。
他認為,在難以知道未來貿易戰會如何發展時,會做好自己,並指公司除了有汽車模具業務外,亦有家居電器產品模具業務可以分散風險。另外,現時沒有在海外設廠的打算。
財務總監劉華平指,現時公司的研發費用佔銷售收入約4%,未來亦會維持在此水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.